Everest Medicines Limited 13D and 13G filings for NovaBridge Biosciences:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2025-08-05 4:00 pm Purchase | 2025-08-05 | 13D | NovaBridge Biosciences NBP | Everest Medicines Limited | 42,524,716 16.100% | 42,524,716 (New Position) | Filing |